Table 1.
Characteristic | Categories | N (%) |
---|---|---|
Publication year | ≤2006 | 0 (0) |
2007–2010 | 3 (23.1) | |
2011–2015 | 4 (30.8) | |
≥2016 | 6 (46.2) | |
Participants | Healthy adults | 6 (46.2) |
Adults with health problems | 5 (38.5) | |
Not reported | 2 (15.4) | |
Country/Regions | China | 4 (30.8) |
Korea | 4 (30.8) | |
Japan | 4 (30.8) | |
Taiwan | 1 (7.7) | |
Study Design | Randomized control group | 3 (23.1) |
Nonequivalent control group pre-posttest design | 5 (38.5) | |
One group pre-post test design | 5 (38.5) | |
Sample size | ≤20 | 7 (53.8) |
21–50 | 4 (30.8) | |
≥51 | 2 (15.4) | |
Statement of ethical consideration | Yes | 12 (92.3) |
No | 1 (7.7) |